SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-319502
Filing Date
2021-11-04
Accepted
2021-11-04 09:13:22
Documents
47
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d136183d10q.htm   iXBRL 10-Q 1686519
2 EX-31.1 d136183dex311.htm EX-31.1 6559
3 EX-31.2 d136183dex312.htm EX-31.2 6552
4 EX-32.1 d136183dex321.htm EX-32.1 4972
  Complete submission text file 0001193125-21-319502.txt   4911921

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA mgta-20210930.xsd EX-101.SCH 26243
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mgta-20210930_cal.xml EX-101.CAL 32927
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mgta-20210930_def.xml EX-101.DEF 215213
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE mgta-20210930_lab.xml EX-101.LAB 276425
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mgta-20210930_pre.xml EX-101.PRE 241057
10 EXTRACTED XBRL INSTANCE DOCUMENT d136183d10q_htm.xml XML 556574
Mailing Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139
Business Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Magenta Therapeutics, Inc. (Filer) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38541 | Film No.: 211378464
SIC: 2834 Pharmaceutical Preparations